Skip to main content

Journal Club

Cerebrovascular

Inflammatory changes in the aneurysm wall: a review

Journal of NeuroInterventional Surgery | 2010

Rapid review note

Journal Club is a rapid, AI-assisted appraisal layer. It highlights study design, effect estimates, and practice relevance, but it is still a briefing, not a replacement for the paper.

For education only. Not medical advice.

Paper snapshot

Rapid study overview

Open paper

DOI

10.1136/jnis.2009.002055

PMID

N/A

PICO

Population

Human intracranial aneurysm walls, supported by selected animal-model and pathology studies discussed in the review.

Intervention

Review of evidence linking chronic inflammation to aneurysm wall degeneration, rupture risk, imaging targets, and possible anti-inflammatory treatment concepts.

Comparator

Aneurysm walls with less advanced histologic degeneration or lower inflammatory infiltration.

Outcomes

Histologic features associated with rupture, distribution of inflammatory infiltrates, and implications for rupture-risk imaging and treatment.

Design

Type

Narrative mechanistic review

Randomized

No

Multicenter

N/A

Blinded

N/A

Follow-up

N/A

Primary endpoint

How inflammatory wall changes relate to aneurysm degeneration and rupture-prone histology.

Secondary endpoints

  • Current imaging options for aneurysm wall inflammation
  • Potential biologic treatment targets
  • Histopathologic classification of vulnerable aneurysm walls

Practice impact

What this means

This paper is a biologic review, not a treatment trial. Its main message is that inflammatory cell infiltration, fibrosis, complement activation, and wall degeneration travel together in intracranial aneurysms, which makes inflammation a plausible marker of instability but not yet a standalone reason to change management.

Bottom line

This review supports inflammation as a biologically credible marker of aneurysm wall instability, but it does not justify changing treatment decisions on its own.

Strength of evidence

low

Recommendation

do not change

Why it matters

  • The paper is a narrative synthesis rather than a prospective management study.
  • Its main value is helping interpret wall-enhancement imaging and pathology, not selecting clipping or coiling.
  • The quantitative data are descriptive and mechanistic rather than directly therapeutic.

What would change my mind

  • A prospective study showing that inflammation-focused imaging predicts rupture beyond standard size and morphology factors.
  • Interventional data showing that targeting inflammatory pathways changes aneurysm growth or rupture outcomes.

Critical appraisal

How strong is the paper?

Methods critique

Risk of bias

This is a narrative review without a prespecified search strategy, so selection bias and citation bias are likely.

Confounding

The paper mixes pathology, autopsy, animal, and observational human data, which makes causal interpretation difficult.

Missing data

Key source studies are summarized selectively, and the review does not provide a formal accounting of unpublished or contradictory evidence.

Multiplicity

Multiple mechanistic pathways are discussed, but there is no formal evidence synthesis or weighting of competing explanations.

Notes

  • The strongest data are histopathologic associations rather than prospective rupture prediction.
  • Review-level synthesis cannot establish whether inflammation is a cause of rupture or a marker of wall injury.
  • The paper is still useful for framing biologic hypotheses and imaging targets.

Stats check

NNT

N/A

Effect sizes

  • A meta-analysis cited in the review estimated intracranial aneurysm prevalence at 2.3% of the population.
  • In an autopsy series of unruptured aneurysms, 29% harbored inflammatory cells and 78% of those infiltrates were located in the fundus.

Absolute effects

  • Approximately half of patients with aneurysmal subarachnoid hemorrhage die, and half of survivors have daily-living problems.
  • The review states that 83-84% of aneurysms rupture at the fundus, 14-15% rupture proximally, and only 2% rupture at the neck.

Concerns

  • These numbers come from different source studies rather than one coherent cohort.
  • The paper does not present pooled estimates for most mechanistic claims.
  • The quantitative data support biological plausibility more than a treatment effect.

External validity

Who it applies to

Clinicians and researchers evaluating rupture biology and imaging targets in saccular intracranial aneurysms.

Who it does not

Teams looking for direct trial evidence that a specific anti-inflammatory treatment improves patient outcomes.

Generalizability notes

  • The review spans pathology specimens, autopsy series, and animal models, so applicability depends on the question being asked.
  • It is more useful for hypothesis generation and risk stratification than for bedside treatment selection.
  • The paper focuses on noninfectious sporadic aneurysms rather than mycotic aneurysms.

Evidence trace

Source trace and metadata

Citations (3)

claim_id

methods_critique.risk_of_bias

locator

p. 1

quote

We review the literature on what is known about inflammation in the IA wall

claim_id

stats_check.absolute_effects

locator

p. 2

claim_id

practice_impact.bottom_line

locator

p. 1

quote

We also discuss current options in imaging inflammation and how knowledge of inflammation in IA walls may improve IA treatment.

Metadata

Generated at

2026-03-08T03:10:00Z

Version

manual-pdf-repair-v1